By Albert Allotey Accra, Nov. 15, GNA – Some Civil Society Organisations (CSOs) have called for the urgent need to for a comprehensive approach to managing diabetes, ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...